Why the study?
Are smart insoles cost-effective in preventing ulcer recurrence in people in diabetic foot remission?
Are smart insoles cost-effective in preventing ulcer recurrence in people in diabetic foot remission?
To show that a device designed to prevent diabetic foot ulcers (DFUs) may help to cost-effectively manage patients at a high-risk of recidivism.
No takes yet. Share an insight, caveat, or question.
Najafi et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: